APA (7th ed.) Citation

Maruta, S., Koshima, Y., Debari, Y., Sugihara, C., Takahata, G., Tamura, R., . . . Ooka, Y. (2026). Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology–Systemic Combination Therapy. Current Oncology, 33(5), 286. https://doi.org/10.3390/curroncol33050286

Chicago Style (17th ed.) Citation

Maruta, Susumu, et al. "Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology–Systemic Combination Therapy." Current Oncology 33, no. 5 (2026): 286. https://doi.org/10.3390/curroncol33050286.

MLA (9th ed.) Citation

Maruta, Susumu, et al. "Lenvatinib Combined with New FP Hepatic Arterial Infusion Chemotherapy for Unresectable Hepatocellular Carcinoma: Clinical Efficacy, Vascular Remodeling, and Implications for Immuno-Oncology–Systemic Combination Therapy." Current Oncology, vol. 33, no. 5, 2026, p. 286, https://doi.org/10.3390/curroncol33050286.